Vytrus Biotech Archives

Born2Invest uses cookies in order to improve your experience and make further customizations to how we present our content. By continuing to use our website, you accept and give your consent to our practices as described in the following: our revised Privacy Policy, Cookie Policy, and Terms of Use.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Born2Invest

All posts tagged "Vytrus Biotech"

Vytrus Biotech Expands with New Plant After 200% Stock Surge

Vytrus Biotech Marks Historic 2024 with Sustainability Milestones and 35% Revenue Growth

Vytrus Biotech Achieves Record Growth and Global Recognition in Q1 2025

Vytrus Biotech Achieves 5 Million Euros in Turnover and 2 Million EBITDA in 2024

Vytrus Biotech Reports Its Best Quarter: Record Revenue and Rising EBITDA

Vytrus Biotech Increases Sales By 28% Until June and EBITDA By 40%

Vytrus Biotech Raises 2.3 Million Euros to Finance its Strategic Plan

Vytrus Biotech Increases Its Sales by 32% in the First Quarter of 2024

Vytrus Biotech Plans to Triple Sales and Reach 12 Million in 2027

Vytrus Biotech Increases Sales by 31% and Achieves an EBITDA of €1.5 Million